Angiogenesis Genotyping in the Selection of First-Line Treatment With Either Sunitinib or Pazopanib for Advanced Renal Cell Carcinoma
Oncotarget - United States
doi 10.18632/oncotarget.9229
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 19, 2016
Authors
Publisher
Impact Journals, LLC